Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-24

Clinical Trial Update: Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing mesalazine granules to placebo for preventing recurrence of diverticulitis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalazine Granules (mesalazine)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Diverticulitis | Phase 3 | Status: TERMINATED